Godavari Drugs Limited (BOM:530317)

Godavari Drugs Revenue

In the fiscal year ending March 31, 2026, Godavari Drugs had annual revenue of 1.07B INR, down -6.57%. Godavari Drugs had revenue of 333.04M in the quarter ending March 31, 2026, with 31.19% growth.

• Revenue: 1.07B
• Revenue Growth: -6.57%
• P/S Ratio: 0.89
• Revenue / Employee: 10.06M
• Employees: 106
• Market Cap: 948.47M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.07B	-74.92M	-6.57%
Mar 31, 2025	1.14B	-431.17M	-27.42%
Mar 31, 2024	1.57B	-24.03M	-1.51%
Mar 31, 2023	1.60B	-16.37M	-1.01%
Mar 31, 2022	1.61B	384.48M	31.31%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 18, 2026

Data Sources Report a data error